ACCD - Accolade, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Plymouth Meeting,
United States
Type: Equity
ACCD price evolution
ACCD
| (in millions $) | 31 Jan 2025 | 1 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $188.71 | $185.72 | ||
| Short term investments | $41.93 | $51.31 | ||
| Net receivables | $25.22 | $27.71 | $27.7 | |
| Inventory | ||||
| Total current assets | $274.74 | $275.26 | $284.91 | |
| Long term investments | ||||
| Property, plant & equipment | $44.57 | $46.77 | $47.48 | |
| Goodwill & intangible assets | $434.71 | $443.6 | ||
| Total noncurrent assets | $492.11 | $503.24 | ||
| Total investments | $41.93 | $51.31 | ||
| Total assets | $756.07 | $767.37 | $788.15 | |
| Current liabilities | ||||
| Accounts payable | $9.03 | $19.4 | $32.3 | |
| Deferred revenue | $38.85 | $34.89 | ||
| Short long term debt | $7.19 | $6.65 | ||
| Total current liabilities | $101.02 | $98.44 | $107.85 | |
| Long term debt | $209.1 | $233.4 | $234.56 | |
| Total noncurrent liabilities | $233.66 | $234.84 | ||
| Total debt | $240.59 | $241.21 | ||
| Total liabilities | $333 | $332.1 | $342.69 | |
| Shareholders' equity | ||||
| Retained earnings | -$1105.63 | -$1081.69 | -$1054.1 | |
| Other shareholder equity | $0.03 | -$0.03 | -$0.05 | |
| Total shareholder equity | $435.26 | $445.46 | ||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $185.72 | $321.08 | $365.85 | $433.88 |
| Short term investments | $51.31 | |||
| Net receivables | $27.7 | $26.7 | $30.8 | $11.84 |
| Inventory | ||||
| Total current assets | $284.91 | $365.95 | $409.14 | $453.98 |
| Long term investments | ||||
| Property, plant & equipment | $47.48 | $44.29 | $44.92 | $9.23 |
| Goodwill & intangible assets | $443.6 | $481.39 | $822.59 | $4.62 |
| Total noncurrent assets | $503.24 | $537.12 | $876.39 | $21.53 |
| Total investments | $51.31 | |||
| Total assets | $788.15 | $903.07 | $1285.53 | $475.51 |
| Current liabilities | ||||
| Accounts payable | $32.3 | $25.85 | $24.1 | $12.4 |
| Deferred revenue | $34.89 | $35.34 | $31.14 | $26.27 |
| Short long term debt | $6.65 | $7.28 | $6.59 | |
| Total current liabilities | $107.85 | $119.41 | $111.75 | $79.08 |
| Long term debt | $234.56 | $309.51 | $313.15 | $280.67 |
| Total noncurrent liabilities | $234.84 | $309.87 | $317.98 | $5.59 |
| Total debt | $241.21 | $316.8 | $319.74 | |
| Total liabilities | $342.69 | $429.28 | $429.74 | $84.66 |
| Shareholders' equity | ||||
| Retained earnings | -$1054.1 | -$954.29 | -$494.64 | -$371.52 |
| Other shareholder equity | -$0.05 | |||
| Total shareholder equity | $445.46 | $473.79 | $855.79 | $390.85 |
| (in millions $) | 30 Jul 2025 | 31 Jan 2025 | 1 Oct 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $106.36 | |||
| Cost of revenue | ||||
| Gross Profit | $49.44 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $74.58 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.37 | |||
| Interest expense | $1.69 | |||
| Net income | ||||
| Net income | -$23.93 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $414.29 | $363.14 | $170.36 | |
| Cost of revenue | $222.23 | $198.91 | $93.67 | |
| Gross Profit | $192.06 | $164.24 | $76.69 | |
| Operating activities | ||||
| Research & development | $99.16 | $101.35 | $49.95 | |
| Selling, general & administrative | $162.19 | $180.32 | $65.3 | |
| Total operating expenses | $306.51 | $627.77 | $123.61 | |
| Operating income | -$114.45 | -$463.53 | -$46.92 | |
| Income from continuing operations | ||||
| EBIT | -$104.52 | -$463.53 | -$46.92 | |
| Income tax expense | $1.24 | -$3.62 | $0 | |
| Interest expense | -$5.95 | -$0.26 | $3.72 | |
| Net income | ||||
| Net income | -$99.81 | -$459.65 | -$50.65 | |
| Income (for common shares) | -$99.81 | -$459.65 | -$50.65 | |
| (in millions $) | 1 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$27.59 | -$7.51 | -$21.06 | |
| Operating activities | ||||
| Depreciation | $10.39 | $11.31 | $11.4 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $15.31 | $15.29 | $15.64 | |
| Total cash flows from operations | -$7.12 | $5.95 | $5.21 | |
| Investing activities | ||||
| Capital expenditures | -$1.96 | -$2.11 | -$3.71 | |
| Investments | $10 | -$51.15 | ||
| Total cash flows from investing | -$11.5 | $8.04 | -$53.25 | -$3.71 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.07 | $3 | $2.5 | |
| Net borrowings | -$66.16 | |||
| Total cash flows from financing | $2.08 | $2.07 | $3 | -$63.66 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$12.4 | $2.99 | -$44.3 | -$62.17 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$99.81 | -$459.65 | -$123.12 | -$50.65 |
| Operating activities | ||||
| Depreciation | $45.16 | $46.38 | $42.61 | $8.21 |
| Business acquisitions & disposals | -$260 | -$0.06 | ||
| Stock-based compensation | $60.94 | $72.64 | $72.94 | $9.58 |
| Total cash flows from operations | -$16.17 | -$40.7 | -$62.35 | -$25.23 |
| Investing activities | ||||
| Capital expenditures | -$12.48 | -$7.23 | -$3.62 | -$2.37 |
| Investments | -$51.15 | |||
| Total cash flows from investing | -$63.63 | -$7.23 | -$263.61 | -$2.42 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.6 | $4.99 | $13.3 | $451.14 |
| Net borrowings | -$66.16 | $279.13 | -$22.75 | |
| Total cash flows from financing | -$55.57 | $3.16 | $257.93 | $428.38 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$135.37 | -$44.77 | -$68.03 | $400.73 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.77 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |